PFE vs WBA
Pfizer vs Walgreens Boots Alliance stock: which is the better buy?
Tickerday reads Pfizer as a Hold at 50 and Walgreens Boots Alliance as a Sell at 38. Today, Pfizer is the stronger call.
Try it on the stock you're thinking about. First one free, no account needed.
PFE
Pfizer
Hold50/100
Partly cloudy, with 60% confidence
A year from now: $27 (+7.1%)
WBA
Walgreens Boots Alliance
Sell38/100
Rainy, with 70% confidence
A year from now: $10 (−16.5%)
Under the hood
Factor by factor
The six things Tickerday weighs, each scored 0 to 100. The higher of each pair is in its call's color.
Pfizer
Walgreens Boots Alliance
Overall score
Valuation
Growth
Profitability
Momentum
Financial Health
Sentiment
Where they're headed
Price targets
Each target is measured from the price on the day its stock was read.
Pfizer
Walgreens Boots Alliance
Price when read
PFE$25.21 · Jun 20, 2026
WBA$11.98 · Jun 21, 2026
Next week
PFE$24.50 (−2.8%)
WBA$11.90 (−0.7%)
Next month
PFE$25 (−0.8%)
WBA$12.20 (+1.8%)
Next year
PFE$27 (+7.1%)
WBA$10 (−16.5%)
The numbers
Key numbers
Pfizer
Walgreens Boots Alliance
Market Cap
PFE$143.7B
WBA$10.4B
P / E Ratio
PFE19.2
WBA—
Rev. Growth
PFE+1.4%
WBA+6.2%
Net Margin
PFE+11.8%
WBA-3.9%
Debt / Equity
PFE0.72
WBA4.04
Dividend Yield
PFE6.8%
WBA4.2%
Beta
PFE0.29
WBA0.77
52-Wk Range
PFE$23 – $29
WBA$8 – $13
The argument
The case for and against
Every call has a case against it. Here are both sides, for each stock.
Pfizer PFE
The case for
- Strong profitability with excellent gross margins and healthy net margins.
- A very attractive dividend yield of 6.8% provides significant income for investors.
The case against
- Revenue growth is currently very low, indicating challenges in expanding its top line.
- The stock has experienced negative momentum recently, particularly in the short term.
Walgreens Boots Alliance WBA
The case for
- The company achieved a positive revenue growth of 6.2%.
- The stock has shown a healthy upward trend over the past year.
The case against
- Walgreens is currently unprofitable, indicated by negative EPS and net margin.
- The company carries a high debt-to-equity ratio of over 4.
Tickerday's reads are educational analysis, the same for everyone, not financial advice. Pfizer was read on Jun 20, 2026 and Walgreens Boots Alliance on Jun 21, 2026; each one's page has the full forecast.
Comparing stocks takes hours.
Tickerday takes seconds.
Now try yours
What about your stocks?
You just compared Pfizer and Walgreens Boots Alliance. Type a company you own and get its call, and the why, in seconds. First one free, no account needed.
The receipts
Called it. Then it happened.
Real calls from the Tickerday engine, each one graded against the real price a month later.
Every call is graded
One month after the call, at the closing price.
Palantir Technologies Inc
+52.3%
✓Called it
We said Buy at $122.33 on Jul 30. A month later the price was $186.29.
Graded Aug 28 at the closing price
One blind call costs more
than a year of Tickerday.
Pricing
Start free, right here
Your first analysis is free, no account needed. Tickerday+ takes it from there.
Tickerday+
Pro
Built for fast clarity.
- Clear buy / hold / sell-style insights
- Key risks and opportunities
- Focused market analysis
- 40 priority credits every month
Billed monthly · ≈ $0.30/day
Tickerday+
Most popularPremium
The full why, explained.
- Expanded analysis & learning depth
- Interactive explanations & breakdowns
- Tap to understand key metrics & terms
- 100 priority credits every month
Billed yearly · ≈ $14.08/mo≈ $0.46/day
Cancel anytime.
FAQ
Good questions
Coming soon to the App Store
The market never sleeps.
That doesn't mean you shouldn't get to.
The Tickerday app is almost here — watchlists, daily check-ins, weather-change alerts, and an Almanac that keeps score of every call. We'll watch the market while you sleep, so you never fly blind again.
Free to download the day it lands — the web desk is open now